Anti-VEGF treatment for myopic choroid neovascularization: from molecular characterization to update on clinical application.

The mean CFT decreased from (223±47.43) μm at the baseline to (206±50.87) μm at the end of the follow-up, however, this change did not reach statistical significance ( Table 2 ). 48 When the follow-up was extended to 24 months in a more recent study in Italy, the mean logMAR BCVA of the myopic patients with CNV was improved from 0.47 (20/60 on Snellen chart) to 0.22 (20/30 on Snellen chart), and 46.6% eyes achieved the improvement of at least three Early Treatment of Diabetic Retinopathy Study (ETDRS) lines.

also in 111,027 other papers